Risk for Suicidal Ideation Not Increased With Semaglutide
TUESDAY, Jan. 9, 2024 -- For individuals with overweight or obesity and type 2 diabetes, semaglutide is not associated with an increased risk for suicidal ideation compared with non-glucagon-like peptide 1 receptor (GLP1R) agonist antiobesity...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Depression | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Obesity | Pharmaceuticals | Suicide